Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?

RMD Open

Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.

Published: April 2020

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340518	PMC
http://dx.doi.org/10.1136/rmdopen-2018-000701	DOI Listing

Publication Analysis

increased mtorc1

mtorc1 activation

activation salivary

salivary gland

gland cells

cells cells

cells patients

patients sjögren's

sjögren's syndrome

syndrome mtor

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!